What's to know about alopecia areata? Alopecia areata is an autoimmune disorder that usually results in unpredictable, patchy hair loss. Approximately 7 million people in the U.S. have alopecia areata, and it can affect anyone of any age or gender. There is no cure for alopecia areata although some treatments are available to help hair regrow more quickly. Read now
A clinician diagnoses female pattern hair loss by taking a medical history and examining the scalp. She or he will observe the pattern of hair loss, check for signs of inflammation or infection, and possibly order blood tests to investigate other possible causes of hair loss, including hyperthyroidism, hypothyroidism, and iron deficiency. Unless there are signs of excess androgen activity (such as menstrual irregularities, acne, and unwanted hair growth), a hormonal evaluation is usually unnecessary.
Like Anderson, he started to lose hair at 21 and tried similarly baroque remedies. “At the time, there was nothing except the snake oil you found at the back of muscle magazines.” He rubbed cayenne pepper into his scalp; he hung upside down; he visited a company that promised a miracle cure that turned out to involve a wig glued on to his head. He looked up a few British trichologists and surmised that trichology was a “study of bullshit” then visited an eminent hair surgeon whose eagerness to perform surgery immediately put him off the idea. It was the discovery of Propecia that ultimately “saved” him. “The drug stopped my hair loss. I had no adverse side effects. I regrew my hair on the crown.”
Lee Buckler, CEO of Replicel, stated in an interview this week that he expects Shiseido to release clinical trial results in 2018. This is great news that everything is still on track for the anticipated 2018 release of Replicel’s RCH-01 technology in Japan. Lee mentioned “It’s entirely up to Shiseido what they do in regards to this product. There’s certainly a possibility that they could decide if the data is positive, to launch the product in Japan…”. Yes, it seems likely that if the data is positive, Shiseido would go to market with one of the biggest technological breakthroughs of the century. Full interview here. 
Baldness is not caused by excess testosterone as is commonly thought; nor is it inherited from your maternal grandfather. It’s caused by sensitivity to testosterone: an enzyme converts testosterone into a substance called dihydrotestosterone – which then causes the follicle to shrink and fall out. Male pattern baldness is inherited, but from both or either side of your genetic line. Why men go bald, we’re not sure – though there is a hypothesis that baldness was once a genetic advantage. People tend to associate baldness with virility and wisdom. The bald hunter-gatherer would have been a natural choice for a chieftain back when life expectancies were shorter and bald heads rarer. In our age of appearances not so much. Of 17 male members of Cabinet, two are bald (Chris Grayling and Sajid Javid). Studies correlate baldness with depression; the term “psycho-trichological” is used to describe the feelings of disfigurement, social avoidance and anxiety disorders that often arrive with premature baldness.
This is an organic shampoo which contains the key ingredient Biotin, often said to topically strengthen existing hair strands. Pura d’Or shampoo also has a proprietary ingredient based on Saw Palmetto, which supposedly blocks DHT – the key culprit in pattern baldness. Some users say it hasn’t just protected their existing hair but has promoted the growth of healthy new hair as well.
Besides cost considerations, a hair transplant is generally prescribed as a last resort for permanent hair loss problems. It is also not allowed for people under the age of 25, those with a continuing problem of hair loss, as well as those with other health conditions like uncontrolled diabetes, serious heart problems and hypertension. Patients whose hair loss is caused by other factors, such as a skin or scalp disorder or who suffer from a psychological condition that causes them to pull at their hair are not recommended for this procedure. Since the procedure requires taking a sample from the back of the head, those who do not have enough follicles from this section that can be used for transplant are not also eligible.
Follicum’s origins trace back to 2004, when two Lund University researchers targeting arteriosclerosis stumbled across a modified protein called osteopontin, which grew hair in mice. The researchers knew nothing about the hair-growth industry, but were quickly informed that there were big market demands, especially in Asia. “If you lose hair in Asia, you lose a lot of your credibility,” Jan Alenfall, the C.E.O. of Follicum, said. “This was really a serendipity finding.”
When men have hereditary hair loss, they often get a receding hairline. Many men see bald patches, especially on the top of the head. Women, on the other hand, tend to keep their hairline. They see noticeably thinning hair. The first sign of hair loss for many women is a widening part. In rare cases, men see noticeably thinning hair. And in rare cases, women can see a receding hairline or bald patches. The reasons for this are unknown.
You might think, "It's just hair", but think about this: What would you do if you wake up one day without a single strand of hair on your head? However, as we've mentioned, hair loss is a natural physiological process. In the hair growth cycle, old hair has to be shed in order for new hair to grow. As we age, our body's capacity to produce hair also slows down, similar to when our bones stop growing at a certain point in our lives.
In 1952, a New York dermatologist named Norman Orentreich invented hair plugs. He removed hair from the back of a patient’s head, where it still grew, and grafted it onto the front. In the decades since, the transplantation process has become more refined. Following the lead of the pioneering dermatologist Robert Bernstein, most doctors perform follicular-unit extraction; instead of crudely ripping up large parts of the scalp, they pluck and move individual follicular units.
Disruptions in the normal length of each phase, which can cause hair loss and hair thinning, may be the result of a number of internal and external stimuli. These are also what we call the triggers and causes of your hair loss. As a quick example, dieting can leave the body stressed and in need of important nutrients. Because of this stress, hair growth may be cut shorter than usual and there is an early onset of telogen or shedding of hair.
Follicum’s origins trace back to 2004, when two Lund University researchers targeting arteriosclerosis stumbled across a modified protein called osteopontin, which grew hair in mice. The researchers knew nothing about the hair-growth industry, but were quickly informed that there were big market demands, especially in Asia. “If you lose hair in Asia, you lose a lot of your credibility,” Jan Alenfall, the C.E.O. of Follicum, said. “This was really a serendipity finding.”

As promised, I am providing an update on the highly anticipated development of Shiseido and RCH-01. This may not be the exact update everyone was hoping to hear, but nonetheless, progress and continued development are what we need to succeed. The update in summary is this: according to my source we will be getting the data from Shiseido’s trial of RCH-01 in 2019. There is no scheduled date for the data presentation, but I anticipate it would be within the 1st quarter of the year. 


Finally, if these tests come back normal, your dermatologist may suggest a scalp biopsy of a couple of two-millimeter sections taken from your scalp under local anesthesia ($400 and up). It can determine whether genetic hair loss, telogen effluvium (a condition in which hair falls out from stress or rapid weight gain), or a disease (such as lupus) is the cause of your shedding, and your dermatologist can treat you accordingly.
“Regenerative medicine is a game-changing area of medicine with the potential to fully heal damaged tissues and organs, offering solutions and hope for people who have conditions that today are beyond repair,” Buckler said. “RepliCel is one of the most promising biotech companies to watch in the field of developing medical innovations that are life-changing.”

Finasteride (brand name Propecia) is the closest to a hair loss cure pill that scientists have discovered to date. This is a DHT hair loss cure. DHT is made when 5 alpha reductase converts testosterone, and Propecia has been found to be an effective inhibitor of DHT by preventing this process from happening. It works internally, at the root of the cause. Therefore, DHT sensitive hair follicles in the front and top of the scalp don’t have to fight off nearly as much DHT.

SOURCES: George Cotsarelis, MD, director, Hair and Scalp Clinic, University of Pennsylvania School of Medicine, Philadelphia. Andrew Kaufman, MD, assistant professor, department of dermatology, University of California, Los Angeles; medical director, Center for Dermatology Care, Thousand Oaks, Calif. Tom Barrows, PhD, director of product development, Aderans Research Institute Inc., Atlanta. Cotsarelis, G. and Millar, S.E. Trends in Molecular Medicine, July 2001; vol 7: pp 293-301. American Society for Dermatologic Surgery web site. American Academy of Facial and Reconstructive Plastic Surgery web site. American Hair Loss Council web site. Springer, K. American Family Physician, July 1, 2003; vol 68: pp 93-102. Hair Loss Help web site, "Interview with Dr. Ken Washenik from Bosley." Fuchs, E. Developmental Cell, July 2001: vol 1: pp 13-25.
We know our products deliver the intended results for the overwhelming majority of men and women who use them as directed. How do we know this? Because we have witnessed the results first-hand on customers of every age, race, and hair type. Because we've spent over 10 years developing, evolving and continually perfecting functional hair care products just like this. Because the Veta product line was tested, piloted and proven at select A-list salons prior to being launched to the public.

“I like to know if one of the things that Follicle can do is to right an e-mail or letter, in our as a community (people who are visiting FT website) name, to the first four companies to let them know that they are lots of people who are waiting for their products, and a cure for hair regrowth and hair loss and ask them to give as the update as soon as they can, and release their products asap.”


The follicles on the sides of the scalp are more genetically resistant to DHT, which is why male pattern baldness often results in a “crown” of hair. But its downsides are serious. “With women, finasteride is not an option,” says Dr. Wolfeld. “It’s not FDA-approved for women to take, so we don’t prescribe it.” In fact, due to the drug’s effect on hormone levels, pregnant women are advised to not even touch broken or crushed tablets.
And though this treatment appears to be safe and somewhat effective, it’s hard to tell who will react well to this low-level light therapy, which is why the doctors I spoke with were hesitant to fully endorse it. “We’re not sure what the optimal power is, what the optimal wavelength is, we don’t even really know the mechanism of action of how this is working,” says Rieder. Plus, it doesn’t work on everyone. “There are subpopulations of patients who do respond to low-level laser light, but this is not easily predictable,” explains McMichael, though she adds that the risk of using the LaserComb is low.
See a doctor. While it may be easy to treat hair loss that's caused by stress or other physical or emotional shock, other types, especially those caused by medical conditions, require expert attention. Do not self-medicate. A medical test is necessary to determine the real cause of your hair loss. A medical diagnosis is important in order to rule out other factors that might be the cause of your hair loss. On the surface, it's easy to attribute hair loss to stress or the lack of sleep, but it is highly possible that the hair loss may be caused by an unknown or undetected condition related to hormones or genetics. With the right diagnosis, you'll be able to get the right medication and course of treatment.
Literally jumping right out of the woodwork, the company “HCell” has announced they have been granted an orphan designation from the US FDA for their novel treatment of pediatric alopecia areata. The treatment itself it described as a “topical Injection by regenerating hair through a proprietary blend of commercially procured biologic and autologous tissue.” The company also mentions having a treatment for androgenic alopecia in the works as well. More info to come soon. News release here. 
“The DHT hormone (dihydrotestosterone) can contribute to thinning in women who are genetically predisposed to female pattern thinning,” Fusco says. For those whose case falls into this category, she advises a prescription shampoo with ketoconazole 2 percent, as it has anti-androgenic properties. “Ketoconazole has been proposed to disrupt the pathway of DHT leading to thinning of follicles.”
Alexey Terskikh PhD of Sanford Burnham Prebys research institute has news to share about his hair follicle research. The Articles page gives you all the highlights on what advancements Terskikh has made over the past three years and when he is planning to take his cloning method to FDA human trials. This is one example of a peer reviewed journal article which actually developed to human translation in a timely manner. Happy Friday
I’d come to think that the simplest answer was the right one: this was regular male-pattern baldness, elaborately covered up. But the Air Force One incident only deepened the mystery. What kind of hair afflicted by male-pattern baldness rises in the back? I suddenly had no idea which parts of his head contained which hairs. Watching the flaps on the back of his head shoot up again and again, I became unmoored in my beliefs.
Because hair concealers work like wigs, choosing one that's right for you is important. More than anything, it should be as natural looking and as subtle as possible. Pick one that matches your natural hair color. Most hair fibers come in nine colors, and if you want to achieve a good color fit, you can blend two colors. Apply first the dark color and then the lighter color.
While some medical practitioners are still on the fence about the effectiveness of laser treatments, studies have found that hair growth using laser therapy increased by 19 normal-size hairs per square centimetre. The regrowth is also observed as thicker, shinier and more manageable. It's a non-invasive, painless procedure that works for both men and women. However, the LLLT is not a stand-alone cure and is thus used in combination with other treatments.
About one-third of women experience hair loss (alopecia) at some time in their lives; among postmenopausal women, as many as two-thirds suffer hair thinning or bald spots. Hair loss in women often has a greater impact than hair loss does on men w, because it's less socially acceptable for them. Alopecia can severely affect a woman's emotional well-being and quality of life.
A clinical researcher who has spent decades researching the fields of pattern hair loss, alopecia areata, endocrinology of the hair follicle and hair follicle morphogenesis, Hoffmann works in his private practice, as a teaching professor in the Department of Dermatology at the University of Marburg and as a researcher on histopathology on hair diseases. He has participated in dozens of clinical hair studies and is the inventor of TrichoScan®, a computerized technique to measure hair growth.
And, for all of these collective efforts, Christiano reminded me, the only things that have really worked were discovered accidentally. Soon to join minoxidil and finasteride will be Xeljanz, or tofacitinib: originally developed for rheumatoid arthritis, it has remarkable effects on hair growth for patients with alopecia areata, an autoimmune disorder that causes patients to lose hair in big patches over their entire bodies.
This particular research which was published in the Nature journal showed that a synthetic version of sandalwood, called Sandalore, binds to the OR2AT4 receptor in hair folliles and prolongs their anagen (growth) phase. The hair follicles studied were treated in a petri dish. Paus has subsequently announced that a completed clinical trial of 20 female volunteers using a topical version of Sandalore showed a reduction of daily hair loss. There is also another larger clinical trial ongoing now which hopes to confirm the effect and announce results in early 2019. Paus has gone as far to say “there is even a chance that this might be able to bring the hair back.” We’ll keep our fingers crossed.
It's for this reason that grocery stores have shelves stocked full with hair care and hair grooming products of all forms and kinds, for different purposes, and even specialized and customized for use of men and women. In one study, it was found that more than half of the men in the UK use about six to ten hair grooming products alone, from the staple shampoos and conditioners to hair gels and other styling products.
Dr. Hawkshaw and his team were lead to test WAY-316606 for hair growth after studying the effects of cyclosporine A (CsA) on hair growth. They found that CsA reduced the expression of SFRP1 in human hair follicles. After looking for other drug candidates that had a similar effect on SFRP1, WAY-316606 was identified. The team has already tested WAY-316606 on isolated human hair follicles which were donated from hair transplant surgeries, and plans to test the drug in human clinical trials in the future. A timeline for a human clinical trial has not been set yet, Follicle Thought will update this as news is presented.

Tinea capitis requires systemic treatment; topical antifungal agents do not penetrate hair follicles. If the causative agent is a Trichophyton species, treatment options include oral terbinafine (Lamisil), itraconazole (Sporanox), fluconazole (Diflucan), and griseofulvin.15 These agents have similar efficacy rates and potential adverse effects, but griseofulvin requires a longer treatment course. Griseofulvin is the preferred treatment for infections caused by Microsporum species, but definitive studies are lacking.15,16 There are limited data about empiric treatment before culture results are available. Because griseofulvin may have lower cure rates in the treatment of T. tonsurans infections, it may not be as effective when used empirically.15 All close contacts of patients with tinea capitis should be examined for signs of infection and treated, if necessary.
The significance of this study is the new level of accuracy it could bring to the screening of drugs and compounds to induce hair growth. The current model used which has been used in the field for decades is the familiar “mice model” in which chemicals are injected or rubbed onto the back of shaved mice. If the substance gets hair to grow back faster than mice who do not receive the chemical, it is deemed that the substance holds promise for improving hair growth. We have learned time and time again, that substances which grow hair in mice do not always translate well to humans. Ghosh believes his new hair follicle model can provide a solution to this issue.
Again, you’ll want to visit your doctor to get a blood test to check your levels in these vitamins. For example, women who have iron levels lower than 70 nanograms per milliliter are considered deficient. From there, work with your doctor to find an appropriate dose according to your deficiency level. Excessive or unnecessary supplementation can be dangerous.
×